281 reports of this reaction
1.8% of all BUPIVACAINE reports
#9 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME is the #9 most commonly reported adverse reaction for BUPIVACAINE, manufactured by Pacira Pharmaceuticals, Inc.. There are 281 FDA adverse event reports linking BUPIVACAINE to DRUG WITHDRAWAL SYNDROME. This represents approximately 1.8% of all 15,404 adverse event reports for this drug.
Patients taking BUPIVACAINE who experience drug withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME is a less commonly reported adverse event for BUPIVACAINE, but still significant enough to appear in the safety profile.
In addition to drug withdrawal syndrome, the following adverse reactions have been reported for BUPIVACAINE:
The following drugs have also been linked to drug withdrawal syndrome in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME has been reported as an adverse event in 281 FDA reports for BUPIVACAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME accounts for approximately 1.8% of all adverse event reports for BUPIVACAINE, making it a notable side effect.
If you experience drug withdrawal syndrome while taking BUPIVACAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.